Cargando…

Shenmai Injection Improves Energy Metabolism in Patients With Heart Failure: A Randomized Controlled Trial

BACKGROUND: In recent years, the application of Shenmai (SM) injection, a traditional Chinese medicine (TCM), to treat heart failure (HF) has been gradually accepted in China. However, whether SM improves energy metabolism in patients with HF has not been determined due to the lack of high-quality s...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Shao-mei, Ye, Li-fang, Wang, Li-hong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7181884/
https://www.ncbi.nlm.nih.gov/pubmed/32362824
http://dx.doi.org/10.3389/fphar.2020.00459
_version_ 1783526139976744960
author Wang, Shao-mei
Ye, Li-fang
Wang, Li-hong
author_facet Wang, Shao-mei
Ye, Li-fang
Wang, Li-hong
author_sort Wang, Shao-mei
collection PubMed
description BACKGROUND: In recent years, the application of Shenmai (SM) injection, a traditional Chinese medicine (TCM), to treat heart failure (HF) has been gradually accepted in China. However, whether SM improves energy metabolism in patients with HF has not been determined due to the lack of high-quality studies. We aimed to investigate the influence of SM on energy metabolism in patients with HF. METHODS: This single-blind, controlled study randomly assigned 120 eligible patients equally into three groups receiving SM, trimetazidine (TMZ), or control in addition to standard medical treatment for HF for 7 days. The primary endpoints were changes in free fatty acids (FFAs), glucose, lactic acid (LA), pyroracemic acid (pyruvate, PA) and branched chain amino acids (BCAAs) in serum. The secondary outcomes included the New York Heart Association (NYHA) functional classification, TCM syndrome score (TCM-s), left ventricular injection fraction (LVEF), left ventricular internal diastolic diameter (LVIDd), left ventricular internal dimension systole (LVIDs), and B-type natriuretic peptide (BNP). RESULTS: After treatment for 1 week, the NYHA functional classification, TCM-s, and BNP level gradually decreased in the patients in all three groups, but these metrics were significantly increased in the patients in the SM group compared with those in the patients in the TMZ and control groups (P < 0.05). Moreover, energy metabolism was improved in the NYHA III–IV patients in the SM group compared with those in the patients in the TMZ and control groups as evidenced by changes in the serum levels of FFA, LA, PA, and BCAA. CONCLUSIONS: Integrative treatment with SM in addition to standard medical treatment for HF was associated with improved cardiac function compared to standard medical treatment alone. The benefit of SM in HF may be related to an improvement in energy metabolism, which seems to be more remarkable than that following treatment with TMZ.
format Online
Article
Text
id pubmed-7181884
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-71818842020-05-01 Shenmai Injection Improves Energy Metabolism in Patients With Heart Failure: A Randomized Controlled Trial Wang, Shao-mei Ye, Li-fang Wang, Li-hong Front Pharmacol Pharmacology BACKGROUND: In recent years, the application of Shenmai (SM) injection, a traditional Chinese medicine (TCM), to treat heart failure (HF) has been gradually accepted in China. However, whether SM improves energy metabolism in patients with HF has not been determined due to the lack of high-quality studies. We aimed to investigate the influence of SM on energy metabolism in patients with HF. METHODS: This single-blind, controlled study randomly assigned 120 eligible patients equally into three groups receiving SM, trimetazidine (TMZ), or control in addition to standard medical treatment for HF for 7 days. The primary endpoints were changes in free fatty acids (FFAs), glucose, lactic acid (LA), pyroracemic acid (pyruvate, PA) and branched chain amino acids (BCAAs) in serum. The secondary outcomes included the New York Heart Association (NYHA) functional classification, TCM syndrome score (TCM-s), left ventricular injection fraction (LVEF), left ventricular internal diastolic diameter (LVIDd), left ventricular internal dimension systole (LVIDs), and B-type natriuretic peptide (BNP). RESULTS: After treatment for 1 week, the NYHA functional classification, TCM-s, and BNP level gradually decreased in the patients in all three groups, but these metrics were significantly increased in the patients in the SM group compared with those in the patients in the TMZ and control groups (P < 0.05). Moreover, energy metabolism was improved in the NYHA III–IV patients in the SM group compared with those in the patients in the TMZ and control groups as evidenced by changes in the serum levels of FFA, LA, PA, and BCAA. CONCLUSIONS: Integrative treatment with SM in addition to standard medical treatment for HF was associated with improved cardiac function compared to standard medical treatment alone. The benefit of SM in HF may be related to an improvement in energy metabolism, which seems to be more remarkable than that following treatment with TMZ. Frontiers Media S.A. 2020-04-17 /pmc/articles/PMC7181884/ /pubmed/32362824 http://dx.doi.org/10.3389/fphar.2020.00459 Text en Copyright © 2020 Wang, Ye and Wang http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Pharmacology
Wang, Shao-mei
Ye, Li-fang
Wang, Li-hong
Shenmai Injection Improves Energy Metabolism in Patients With Heart Failure: A Randomized Controlled Trial
title Shenmai Injection Improves Energy Metabolism in Patients With Heart Failure: A Randomized Controlled Trial
title_full Shenmai Injection Improves Energy Metabolism in Patients With Heart Failure: A Randomized Controlled Trial
title_fullStr Shenmai Injection Improves Energy Metabolism in Patients With Heart Failure: A Randomized Controlled Trial
title_full_unstemmed Shenmai Injection Improves Energy Metabolism in Patients With Heart Failure: A Randomized Controlled Trial
title_short Shenmai Injection Improves Energy Metabolism in Patients With Heart Failure: A Randomized Controlled Trial
title_sort shenmai injection improves energy metabolism in patients with heart failure: a randomized controlled trial
topic Pharmacology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7181884/
https://www.ncbi.nlm.nih.gov/pubmed/32362824
http://dx.doi.org/10.3389/fphar.2020.00459
work_keys_str_mv AT wangshaomei shenmaiinjectionimprovesenergymetabolisminpatientswithheartfailurearandomizedcontrolledtrial
AT yelifang shenmaiinjectionimprovesenergymetabolisminpatientswithheartfailurearandomizedcontrolledtrial
AT wanglihong shenmaiinjectionimprovesenergymetabolisminpatientswithheartfailurearandomizedcontrolledtrial